(2Z)-[(4R,5S,6S)-6-(beta-D-Glucopyranosyloxy)-4,5-dihydroxy-2-cyclohexen-1-ylidene]acetonitrile(CAS: 63492-69-3)
![(2Z)-[(4R,5S,6S)-6-(beta-D-Glucopyranosyloxy)-4,5-dihydroxy-2-cyclohexen-1-ylidene]acetonitrile (2Z)-[(4R,5S,6S)-6-(beta-D-Glucopyranosyloxy)-4,5-dihydroxy-2-cyclohexen-1-ylidene]acetonitrile](https://cnstatic.chemtradehub.com/structs/634/63492-69-3-a63b.webp)
CAS号
相关产品
其他供应商提供的 (2Z)-[(4R,5S,6S)-6-(beta-D-Glucopyranosyloxy)-4,5-dihydroxy-2-cyclohexen-1-ylidene]acetonitrile
基本信息
分子式
C14H19NO8
分子量
329.3 g/mol
物理状态
Powder
Physical Properties
熔点
271 ºC (dec.)
密度
1.61
化学标识符
SMILES
C1=C/C(=C/C#N)/[C@@H]([C@H]([C@@H]1O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O
InChIKey
WIIDBJNWXCWLKF-VVAXPEBGSA-N
数据库引用
MDL号
MFCD20527295
常见问题
紫草氰苷适用于GHS(全球化学品统一分类和标签制度)分类中的特定类别,包括但不限于易燃液体、可能致癌物质等。在欧洲市场,还需遵守REACH法规,确保其对人体健康和环境的影响符合要求。在FDA和EPA的规定下,紫草氰苷的使用和管理需遵循相应的安全和环境标准。
合成紫草氰苷时,可以考虑使用其类似物或异构体作为替代品,如紫草素,它们在化学结构上相似,可以满足部分合成需求。此外,还可以使用其他天然产物,如紫草素A或紫草素B,作为合成过程中的前体或替代物。
紫草氰苷的研究趋势主要集中在其生物活性和药理学特性上,特别是在抗炎、抗氧化和抗癌方面。随着对天然产物研究的深入,紫草氰苷在药物开发中的应用需求逐渐增加。市场趋势显示,由于其潜在的健康益处,紫草氰苷及其衍生物的价格可能会有所上涨,特别是在制药和保健品行业。
含有紫草氰苷的废料应首先进行分类收集,避免与其他化学品混合。对于含有紫草氰苷的废液,建议采用中和处理,然后进行过滤和沉淀处理,最后通过焚烧或交由专业废弃物处理公司进行安全处置。在处理过程中,需注意环保法规要求,确保处理过程中的安全和环保。
安全须知
使用前请验证产品规格和安全数据。联系供应商获取详细安全信息。
请始终遵循正确的操作程序

![(6aR)-1,2-Dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline](https://cnstatic.chemtradehub.com/structs/475/475-83-2-566d.webp)
![(14S,27R)-22,33-Dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2~16,19~.1~3,10~.1~21,25~.0~4,8~.0~14,39~.0~31,35~]nonatriaconta-1(33),3,8,10(39),16,18,21(36),22,24,31,34,37-dod
ecaene](https://cnstatic.chemtradehub.com/structs/481/481-49-2-d49c.webp)

![(1S,2R,4R,5R,6S,8R,10S,11S,12R,14R,15R,16R,19S,21R)-6-(3-Furyl)-12,16,19-trihydroxy-5,11,15-trimethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.0~1,14~.0~2,11~.0~5,10~.0~8,10~]henicosane-4,21-diyl diacetate](https://cnstatic.chemtradehub.com/structs/588/58812-37-6-c4a7.webp)

![(2R,3R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,3-dihydrochromen-4-one](https://cnstatic.chemtradehub.com/structs/572/572-31-6-efe4.webp)
![(3β,25S)-Spirost-5-en-3-yl O-6-deoxy-α-L-mannopyranosyl-(1→2)-O-[β-D-xylopyranosyl-(1→3)]-β-D-glucopyranoside](https://cnstatic.chemtradehub.com/structs/874/87480-46-4-e9d4.webp)


![(2Z)-[(4R,5S,6S)-6-(beta-D-Glucopyranosyloxy)-4,5-dihydroxy-2-cyclohexen-1-ylidene]acetonitrile — 云南西力生物技术股份有限公司](https://cnstatic.chemtradehub.com/suppliers/67cecac62b2de6e8e95a5839/67cecac62b2de6e8e95a5839-logo.webp)
![(2Z)-[(4R,5S,6S)-6-(beta-D-Glucopyranosyloxy)-4,5-dihydroxy-2-cyclohexen-1-ylidene]acetonitrile — 上海源叶生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce9f132b2de6e8e95a48fe/67ce9f132b2de6e8e95a48fe-logo.webp)
![(2Z)-[(4R,5S,6S)-6-(beta-D-Glucopyranosyloxy)-4,5-dihydroxy-2-cyclohexen-1-ylidene]acetonitrile — 成都钠钶锂生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce7d7d2b2de6e8e95a46e1/67ce7d7d2b2de6e8e95a46e1-logo.webp)
![(2Z)-[(4R,5S,6S)-6-(beta-D-Glucopyranosyloxy)-4,5-dihydroxy-2-cyclohexen-1-ylidene]acetonitrile — 上海安谱实验科技股份有限公司](https://cnstatic.chemtradehub.com/suppliers/67cdcfdf57537e5c8069ad2d/67cdcfdf57537e5c8069ad2d-logo.webp)